Literature DB >> 32112474

Alcohol use disorders and the brain.

Rahul Rao1,2, Anya Topiwala3.   

Abstract

A diagnosis of alcohol use disorder is associated with a higher risk of dementia, but a dose-response relationship between alcohol intake consumption and cognitive impairment remains unclear. Alcohol is associated with a range of effects on the central nervous system at different doses and acts on a number of receptors. Acute disorders include Wernicke's encephalopathy (WE), traumatic brain injury, blackouts, seizures, stroke and hepatic encephalopathy. The most common manifestations of chronic alcohol consumption are Korsakoff's syndrome (KS) and alcohol-related dementia (ARD). There is limited evidence for benefit from memantine in the treatment of ARD, but stronger evidence for the use of high-dose parenteral thiamine in the progression of neuropsychiatric symptoms for WE. Accumulating evidence exists for pharmacological treatment in the prevention of hepatic encephalopathy. Rehabilitation of people with ARD may take several years, and requires an approach that addresses physical and psychosocial factors.
© 2020 Society for the Study of Addiction.

Entities:  

Keywords:  Alcohol; Korsakoff's syndrome; Wernicke's encephalopathy; dementia: brain; hepatic encephalopathy; thiamine

Mesh:

Year:  2020        PMID: 32112474     DOI: 10.1111/add.15023

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  6 in total

1.  Identifying Alcohol Use Disorder With Resting State Functional Magnetic Resonance Imaging Data: A Comparison Among Machine Learning Classifiers.

Authors:  Victor M Vergara; Flor A Espinoza; Vince D Calhoun
Journal:  Front Psychol       Date:  2022-06-10

2.  Preventive Measures against the Development of Dementia in Old Age.

Authors:  Israel Oluwasegun Ayenigbara
Journal:  Korean J Fam Med       Date:  2022-05-20

3.  Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile.

Authors:  Vatsalya Vatsalya; Fengyuan Li; Jane Frimodig; Khushboo S Gala; Shweta Srivastava; Maiying Kong; Vijay A Ramchandani; Wenke Feng; Xiang Zhang; Craig J McClain
Journal:  Front Pharmacol       Date:  2021-03-02       Impact factor: 5.810

4.  Association of Plasma Anion Gap with 28-Day Inhospital Mortality and 1-Year Mortality of Patients with Alcohol Use Disorder at ICU Admission: A Retrospective Cohort Study.

Authors:  Yu Pan; Xiaoyang Miao; Ou Jin; Jingye Pan; Yihua Dong
Journal:  Dis Markers       Date:  2022-09-07       Impact factor: 3.464

5.  Impact of alcohol-induced intestinal microbiota dysbiosis in a rodent model of Alzheimer's disease.

Authors:  Dulce M Frausto; Phillip A Engen; Ankur Naqib; Aeja Jackson; Laura Tran; Stefan J Green; Maliha Shaikh; Christopher B Forsyth; Ali Keshavarzian; Robin M Voigt
Journal:  Front Aging       Date:  2022-08-15

6.  Ascorbic Acid Deficiency Prevalence and Associated Cognitive Impairment in Alcohol Detoxification Inpatients: A Pilot Study.

Authors:  Virgile Clergue-Duval; Julien Azuar; Julien Fonsart; Clément Delage; Dorian Rollet; Jihed Amami; Alexia Frapsauce; Marie-Astrid Gautron; Eric Hispard; Frank Bellivier; Vanessa Bloch; Jean-Louis Laplanche; Frank Questel; Florence Vorspan
Journal:  Antioxidants (Basel)       Date:  2021-11-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.